Pancreatic Cancer Research

ResearcherChinese PLA General HospitalNo recent work listed

Yan Gong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2945-3228; OpenAlex author ID A5101895001. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 3

  1. Diagnostic and Prognostic Performance of MicroRNA-25, Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 125 in Pancreatic Ductal Ad… Co-author DOI 10.30476/ijms.2022.95583.2705↗
  2. Metabolic detection and systems analyses of pancreatic ductal adenocarcinoma through machine learning, lipidomics, and multi-omics. Co-author DOI 10.1126/sciadv.abh2724↗
  3. RETRACTED: GATA4 inhibits cell differentiation and proliferation in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0202449↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qiang Zeng · 2 shared papers, 2021–2023 · strength 0.32
  2. Lele Song · 1 shared paper, 2023 · strength 0.22
  3. Qiang Zeng · 1 shared paper, 2018 · strength 0.10
  4. Xin Chen · 1 shared paper, 2018 · strength 0.10
  5. Zipeng Lu · 1 shared paper, 2021 · strength 0.10
  6. Yinmo Yang · 1 shared paper, 2021 · strength 0.10
  7. Yongsu Ma · 1 shared paper, 2021 · strength 0.10
  8. Guangxi Wang · 1 shared paper, 2021 · strength 0.10
  9. Yuxin Yin · 1 shared paper, 2021 · strength 0.10
  10. Kuirong Jiang · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.